Skip to content

Study on the early intervention effect of dextrin resistance on sugar

Study on the early intervention effect of dextrin resistance on sugar

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200062444
Enrollment
Unknown
Registered
2022-08-07
Start date
2022-09-01
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prediabetes

Interventions

Intervention group:Take 10g of DEXtrin every day before lunch
Control group:Placebo maltodextrin 4.7g/d before lunch every day

Sponsors

Qilu Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. People aged 35-75, regardless of gender; 2. BMI between 18 and 32kg/ m2, stable body weight (+/-4 kg) in the past 2 months; 3. Diagnosis of prediabetes-impaired fasting glucose: fasting glucose between 6.1 and 7.0mmol/ L and blood glucose < 7.8mmol/ L 2 hours after glucose load or diagnosis of prediabetes -- impaired glucose tolerance: fasting glucose < 7.0mmol/ L and blood glucose between 7.8 and 11.1mmol/ L 2 hours after glucose load; 4. Understands and agrees to participate in a study.

Exclusion criteria

Exclusion criteria: 1. HbA1c concentration >7% was excluded. 2. Pregnancy and lactation were excluded; Patients suffering from serious acute or chronic diseases, such as malignant tumors; 3. Exclude people who have diseases that raise blood sugar or take drugs that affect blood sugar; 4. People taking diabetes medications were excluded; 5. Exclude any other diseases or conditions that may limit study adherence; 6. People with daily dietary fiber intake of more than 30g were excluded; 7. Exclude glucocorticoids, antibiotics, prebiotics, probiotics, vitamin supplements, and any other drugs that might interfere with microbiome analysis.

Design outcomes

Primary

MeasureTime frame
FBG(fasting blood-glucose);2h postprandial blood glucose;Glycosylated hemoglobin;Insulin resistance index;C-reactive protein;Triglyceride;High density lipoprotein (HDL);Low density lipoprotein (LDL);Cholesterol;

Secondary

MeasureTime frame
Height;Weight;Waistline;Hipline;Blood pressure;

Countries

China

Contacts

Public ContactLiyong Chen

Qilu Hospital of Shandong University

chenle73@sina.com+86 18560085613

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026